33
Treatment of Insomnia
ROXANNE TAYLOR
NOTE: This chapter corresponds to Chapter 39 in Fundamentals of Sleep Technology, 2nd edition.
1. Some patients receive substantial attention, special consideration, and sympathy for the misery associated with insomnia, influencing decisions regarding treatment. What is this psychological process referred to?
A. The Hawthorne effect
B. Secondary gain
C. Transference
D. Empathy burnout
2. Depressed patients with insomnia benefit more from treatment of both disorders than from treatments aimed at only one or the other disorder. In these patients, insomnia and depression are said to be:
A. Comorbid
B. Causal
C. Complex
D. Chronic
3. Identify an effective way to instruct patients on proper sleep hygiene.
A. Identify specific sleep hygiene factors that affect the patient and individualize care.
B. Detail all sleep hygiene measures and implement them all simultaneously.
C. Provide a pamphlet and let the patient work it out on his or her own.
D. Skip sleep hygiene as a treatment because it is not effective.
4. Which of the following is a component of stimulus control therapy?
A. Imagining being on a beach in Hawaii drinking a piña colada from a cocoanut
B. Keeping the bedroom as cold and dark as possible
C. Keeping a pet off the bed
D. Getting out of bed if unable to fall asleep within 15 minutes
5. Cognitive therapy focuses on:
A. Distracting the patient who obsesses about sleep
B. Thinking up ways to fool your brain into falling asleep
C. Using muscle relaxation to reduce the level of anxiety
D. Changing dysfunctional beliefs about sleep
6. Side effects of benzodiazepine use include memory impairment, accidents, tolerance, dependence, abuse, withdrawal, and, in the case of agents with a prolonged half-life:
A. Daytime sedation
B. Daytime anxiety
C. Increased incidence of rebound insomnia
D. Sleep terrors
7. Which of the following class of medications is commonly used for insomnia but is not approved by the U.S. Food and Drug Administration (FDA) for this indication?
A. Melatonin receptor agonists
B. Benzodiazepines
C. Selective serotonin reuptake inhibitors
D. Nonbenzodiazepine benzodiazepine receptor agonists
8. What is the definition of perpetuating factors for insomnia?
A. Vulnerability to biologic and psychological factors
Related posts:
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
